Enterprise Value
-46.45M
Cash
294M
Avg Qtr Burn
-25.64M
Short % of Float
16.83%
Insider Ownership
10.06%
Institutional Own.
77.11%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CB-012 Details Acute myeloid leukemia, Cancer | Phase 1 Data readout | |
CB-011 Details Cancer, Blood cancer, Multiple myeloma | Phase 1 Data readout | |
CB-010 Details Non-Hodgkin lymphoma, Cancer, Blood cancer | Phase 1 Data readout | |
CB-010 Details Lupus nephritis, Extrarenal lupus | Phase 1 Initiation |